1. Home
  2. CRNX vs MIST Comparison

CRNX vs MIST Comparison

Compare CRNX & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • MIST
  • Stock Information
  • Founded
  • CRNX 2008
  • MIST 2003
  • Country
  • CRNX United States
  • MIST Canada
  • Employees
  • CRNX N/A
  • MIST N/A
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • MIST Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRNX Health Care
  • MIST Health Care
  • Exchange
  • CRNX Nasdaq
  • MIST Nasdaq
  • Market Cap
  • CRNX N/A
  • MIST 53.9M
  • IPO Year
  • CRNX 2018
  • MIST N/A
  • Fundamental
  • Price
  • CRNX $31.68
  • MIST $1.12
  • Analyst Decision
  • CRNX Strong Buy
  • MIST Strong Buy
  • Analyst Count
  • CRNX 12
  • MIST 2
  • Target Price
  • CRNX $73.36
  • MIST $9.50
  • AVG Volume (30 Days)
  • CRNX 822.9K
  • MIST 1.6M
  • Earning Date
  • CRNX 05-08-2025
  • MIST 05-20-2025
  • Dividend Yield
  • CRNX N/A
  • MIST N/A
  • EPS Growth
  • CRNX N/A
  • MIST N/A
  • EPS
  • CRNX N/A
  • MIST N/A
  • Revenue
  • CRNX $1,039,000.00
  • MIST N/A
  • Revenue This Year
  • CRNX $356.40
  • MIST N/A
  • Revenue Next Year
  • CRNX $700.38
  • MIST N/A
  • P/E Ratio
  • CRNX N/A
  • MIST N/A
  • Revenue Growth
  • CRNX N/A
  • MIST N/A
  • 52 Week Low
  • CRNX $24.10
  • MIST $0.63
  • 52 Week High
  • CRNX $62.53
  • MIST $2.75
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 58.07
  • MIST 46.48
  • Support Level
  • CRNX $30.35
  • MIST $1.28
  • Resistance Level
  • CRNX $34.68
  • MIST $1.32
  • Average True Range (ATR)
  • CRNX 1.43
  • MIST 0.12
  • MACD
  • CRNX 0.23
  • MIST 0.03
  • Stochastic Oscillator
  • CRNX 88.91
  • MIST 38.80

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: